Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients

Sei Hyun Ahn, Ui Kang Hwang, Beom Seok Kwak, Ho Sung Yoon, Bo Kyung Ku, Hee Jun Kang, Ji Su Kim, Byung Kyun Ko, Chang Dae Ko, Kyung Sik Yoon, Dae Yeon Cho, Jun Suk Kim, Byung Ho Son

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The incidence of breast cancer in Korea has been increasing in recent years, such that it is now the most common female cancer. Breast cancer in Korea is characterized by an earlier age of onset than in Western countries, suggesting that it would be related with genetic background. We assayed germline mutations in the BRCA genes to evaluate their genetic pathology in Korean breast cancer patients. The study subjects consisted of 173 patients at clinically higher risk and 109 unselected patients. Germline mutations in the entire coding sequences of the BRCA1 and BRCA2 genes were analyzed by Conformation-Sensitive Gel Electrophoresis (CSGE), and any aberrantly-sized band was sequenced. BRCA mutations were present in 12.7% of the high risk patients, compared with 2.8% of the unselected patients. Among high risk patients, mutations were most prevalent in patients with a family history of breast or first-degree ovarian cancer (22.1%), followed by those with male breast cancer (20%), bilateral breast cancer (20%), multiple organ cancer including breast (13%) and younger breast cancer patients (aged <35 yr) (8.1%). Moreover, BRCA mutations were detected in 34.8% of patients having two high-risk factors. These findings suggest that BRCA gene mutation analysis should be performed on Korean patients with high-risk factors for breast cancer.

Original languageEnglish
Pages (from-to)269-274
Number of pages6
JournalJournal of Korean Medical Science
Volume19
Issue number2
Publication statusPublished - 2004 Apr 1

Fingerprint

Breast Neoplasms
Mutation
Germ-Line Mutation
Korea
BRCA2 Gene
Male Breast Neoplasms
BRCA1 Gene
Age of Onset
Ovarian Neoplasms
Genes
Electrophoresis
Breast
Gels
Pathology
Incidence
Neoplasms

Keywords

  • BRCA1
  • Breast Neoplasms
  • Genes
  • Koreans
  • Prevalence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ahn, S. H., Hwang, U. K., Kwak, B. S., Yoon, H. S., Ku, B. K., Kang, H. J., ... Son, B. H. (2004). Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. Journal of Korean Medical Science, 19(2), 269-274.

Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. / Ahn, Sei Hyun; Hwang, Ui Kang; Kwak, Beom Seok; Yoon, Ho Sung; Ku, Bo Kyung; Kang, Hee Jun; Kim, Ji Su; Ko, Byung Kyun; Ko, Chang Dae; Yoon, Kyung Sik; Cho, Dae Yeon; Kim, Jun Suk; Son, Byung Ho.

In: Journal of Korean Medical Science, Vol. 19, No. 2, 01.04.2004, p. 269-274.

Research output: Contribution to journalArticle

Ahn, SH, Hwang, UK, Kwak, BS, Yoon, HS, Ku, BK, Kang, HJ, Kim, JS, Ko, BK, Ko, CD, Yoon, KS, Cho, DY, Kim, JS & Son, BH 2004, 'Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients', Journal of Korean Medical Science, vol. 19, no. 2, pp. 269-274.
Ahn SH, Hwang UK, Kwak BS, Yoon HS, Ku BK, Kang HJ et al. Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. Journal of Korean Medical Science. 2004 Apr 1;19(2):269-274.
Ahn, Sei Hyun ; Hwang, Ui Kang ; Kwak, Beom Seok ; Yoon, Ho Sung ; Ku, Bo Kyung ; Kang, Hee Jun ; Kim, Ji Su ; Ko, Byung Kyun ; Ko, Chang Dae ; Yoon, Kyung Sik ; Cho, Dae Yeon ; Kim, Jun Suk ; Son, Byung Ho. / Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. In: Journal of Korean Medical Science. 2004 ; Vol. 19, No. 2. pp. 269-274.
@article{7c815c8e157441fcb99bd38fde054393,
title = "Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients",
abstract = "The incidence of breast cancer in Korea has been increasing in recent years, such that it is now the most common female cancer. Breast cancer in Korea is characterized by an earlier age of onset than in Western countries, suggesting that it would be related with genetic background. We assayed germline mutations in the BRCA genes to evaluate their genetic pathology in Korean breast cancer patients. The study subjects consisted of 173 patients at clinically higher risk and 109 unselected patients. Germline mutations in the entire coding sequences of the BRCA1 and BRCA2 genes were analyzed by Conformation-Sensitive Gel Electrophoresis (CSGE), and any aberrantly-sized band was sequenced. BRCA mutations were present in 12.7{\%} of the high risk patients, compared with 2.8{\%} of the unselected patients. Among high risk patients, mutations were most prevalent in patients with a family history of breast or first-degree ovarian cancer (22.1{\%}), followed by those with male breast cancer (20{\%}), bilateral breast cancer (20{\%}), multiple organ cancer including breast (13{\%}) and younger breast cancer patients (aged <35 yr) (8.1{\%}). Moreover, BRCA mutations were detected in 34.8{\%} of patients having two high-risk factors. These findings suggest that BRCA gene mutation analysis should be performed on Korean patients with high-risk factors for breast cancer.",
keywords = "BRCA1, Breast Neoplasms, Genes, Koreans, Prevalence",
author = "Ahn, {Sei Hyun} and Hwang, {Ui Kang} and Kwak, {Beom Seok} and Yoon, {Ho Sung} and Ku, {Bo Kyung} and Kang, {Hee Jun} and Kim, {Ji Su} and Ko, {Byung Kyun} and Ko, {Chang Dae} and Yoon, {Kyung Sik} and Cho, {Dae Yeon} and Kim, {Jun Suk} and Son, {Byung Ho}",
year = "2004",
month = "4",
day = "1",
language = "English",
volume = "19",
pages = "269--274",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "2",

}

TY - JOUR

T1 - Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients

AU - Ahn, Sei Hyun

AU - Hwang, Ui Kang

AU - Kwak, Beom Seok

AU - Yoon, Ho Sung

AU - Ku, Bo Kyung

AU - Kang, Hee Jun

AU - Kim, Ji Su

AU - Ko, Byung Kyun

AU - Ko, Chang Dae

AU - Yoon, Kyung Sik

AU - Cho, Dae Yeon

AU - Kim, Jun Suk

AU - Son, Byung Ho

PY - 2004/4/1

Y1 - 2004/4/1

N2 - The incidence of breast cancer in Korea has been increasing in recent years, such that it is now the most common female cancer. Breast cancer in Korea is characterized by an earlier age of onset than in Western countries, suggesting that it would be related with genetic background. We assayed germline mutations in the BRCA genes to evaluate their genetic pathology in Korean breast cancer patients. The study subjects consisted of 173 patients at clinically higher risk and 109 unselected patients. Germline mutations in the entire coding sequences of the BRCA1 and BRCA2 genes were analyzed by Conformation-Sensitive Gel Electrophoresis (CSGE), and any aberrantly-sized band was sequenced. BRCA mutations were present in 12.7% of the high risk patients, compared with 2.8% of the unselected patients. Among high risk patients, mutations were most prevalent in patients with a family history of breast or first-degree ovarian cancer (22.1%), followed by those with male breast cancer (20%), bilateral breast cancer (20%), multiple organ cancer including breast (13%) and younger breast cancer patients (aged <35 yr) (8.1%). Moreover, BRCA mutations were detected in 34.8% of patients having two high-risk factors. These findings suggest that BRCA gene mutation analysis should be performed on Korean patients with high-risk factors for breast cancer.

AB - The incidence of breast cancer in Korea has been increasing in recent years, such that it is now the most common female cancer. Breast cancer in Korea is characterized by an earlier age of onset than in Western countries, suggesting that it would be related with genetic background. We assayed germline mutations in the BRCA genes to evaluate their genetic pathology in Korean breast cancer patients. The study subjects consisted of 173 patients at clinically higher risk and 109 unselected patients. Germline mutations in the entire coding sequences of the BRCA1 and BRCA2 genes were analyzed by Conformation-Sensitive Gel Electrophoresis (CSGE), and any aberrantly-sized band was sequenced. BRCA mutations were present in 12.7% of the high risk patients, compared with 2.8% of the unselected patients. Among high risk patients, mutations were most prevalent in patients with a family history of breast or first-degree ovarian cancer (22.1%), followed by those with male breast cancer (20%), bilateral breast cancer (20%), multiple organ cancer including breast (13%) and younger breast cancer patients (aged <35 yr) (8.1%). Moreover, BRCA mutations were detected in 34.8% of patients having two high-risk factors. These findings suggest that BRCA gene mutation analysis should be performed on Korean patients with high-risk factors for breast cancer.

KW - BRCA1

KW - Breast Neoplasms

KW - Genes

KW - Koreans

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=2342621289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342621289&partnerID=8YFLogxK

M3 - Article

C2 - 15082902

AN - SCOPUS:2342621289

VL - 19

SP - 269

EP - 274

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 2

ER -